The world's largest and most successful trade fair for Laboratory Technology, Analysis and Biotechnology, analytica takes ...

Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to ...

Presentations in this conference track covered the latest technological advances and methods in microfluidics devices. In the keynote address “Commercialization and Entrepreneurial Lessons from ...

In addition, Der Simulierte Mensch (Si-M), The Simulated Human, a new research center, is being finalized in Berlin to open in 2026. Neubauer explains this is a joint partnership between TU Berlin and ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

NVIDIA (NVDA) on Monday said it is expanding its BioNeMo platform for AI-driven biology and drug discovery, unveiling new software models, data tools and partnerships aimed at linking artificial ...

Every stage of biopharma drug development depends on what happens in the laboratory. Consequently, any one of these stages—which include target identification, lead optimization, candidate screening, ...

Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. No topic has been discussed more than Covid-19 in the past two ...

Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized ...

San Francisco, 06 May 2025: Trilobio, which is building an automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led ...